These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 14391648)

  • 1. [Possibilities in the field of new anti-tuberculosis drugs].
    MASCHERPA P
    G Ital Chemioter; 1954; 1(3-4):340-65. PubMed ID: 14391648
    [No Abstract]   [Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biologic effects of isoniazid].
    FREERKSEN E
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 110(1-2):97-106. PubMed ID: 13140095
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of combined tobramycin-clarithromycin on Mycobacterium tuberculosis isolates.
    Stoffels K; Traore H; Vanderbist F; Fauville-Dufaux M
    Int J Tuberc Lung Dis; 2009 Aug; 13(8):1041-4. PubMed ID: 19723387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998].
    Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA
    Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A year's therapy with isoniazid; bacteriological resistance and therapeutic results].
    MEISSNER G; BERG G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 111(4):340-52. PubMed ID: 13181801
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
    Dutta NK; Mazumdar K; Dastidar SG; Park JH
    Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical testing of new drugs for tuberculosis: current challenges.
    Lenaerts AJ; Degroote MA; Orme IM
    Trends Microbiol; 2008 Feb; 16(2):48-54. PubMed ID: 18182291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drugs and vaccines.
    Yeager H
    Dis Mon; 2007 Jan; 53(1):59-63. PubMed ID: 17224325
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of Mycobacterium tuberculosis eradication before segmental lung resection in tuberculosis].
    Kazanchian PO
    Zh Eksp Klin Med; 1968; 8(4):78-83. PubMed ID: 16541578
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-TB drug resistance levels and patterns among Mycobacterium tuberculosis isolated from newly diagnosed cases of pulmonary tuberculosis in Dar es Salaam, Tanzania.
    Matee M; Mfinanga S; Holm-Hansen C
    APMIS; 2009 Apr; 117(4):263-7. PubMed ID: 19338514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
    Donald PR; Diacon AH
    Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua.
    Chacón L; Lainez M; Rosales E; Mercado M; Caminero JA
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):62-7. PubMed ID: 19105880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis--current therapeutic concepts].
    Grünhage F; Sauerbruch T; Spengler U
    Dtsch Med Wochenschr; 2005 Jan; 130(4):159-64. PubMed ID: 15662583
    [No Abstract]   [Full Text] [Related]  

  • 17. The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey.
    Ozturk CE; Balbay OA; Kaya D; Ceyhan I; Bulut I; Sahin I
    Jpn J Infect Dis; 2005 Feb; 58(1):47-9. PubMed ID: 15728994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Case of multi-drug resistant pulmonary tuberculosis with bilateral cavitary lesions successfully treated by surgical treatment].
    Okumura M; Ogata H; Yoshiyama T; Kokutoh H; Tadokoro E; Kubota M; Ueyama M; Wada M; Nakajima Y
    Kekkaku; 2007 Nov; 82(11):831-5. PubMed ID: 18078108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis.
    Bapela NB; Lall N; Fourie PB; Franzblau SG; Van Rensburg CE
    Phytomedicine; 2006 Nov; 13(9-10):630-5. PubMed ID: 16987644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial drug resistance as a threat for tuberculosis control: the case of Buenaventura, Colombia].
    Moreira CA; Hernández HL; Arias NL; Castaño MC; Ferro BE; Jaramillos E
    Biomedica; 2004 Jun; 24 Supp 1():73-9. PubMed ID: 15495574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.